109
Views
3
CrossRef citations to date
0
Altmetric
ARTICLES

Hepatitis C Infection Among Hispanics in California

, MD, MSN, , MD, PhD, , PhD & , DPA

REFERENCES

  • CDC. Surveillance for viral hepatitis—United States, 2011. 2011. http://www.cdc.gov/hepatitis/statistics/2011surveillance/pdfs/2011hepsurveillancerpt.pdf
  • Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3(2):47.
  • El Khoury AC, Klimack WK, Wallace C, Razavi H. Economic burden of hepatitis C-associated diseases in the United States. Journal of Viral Hepatitis 2012; 19(3):153–60.
  • CDC. CDC testing recommendations for chronic hepatitis C virus infection among persons born during 1945–1965—United States, 2013 and health disparities and inequalities Report—United States, 2013. 2013. http://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf
  • Census Bureau U. Overview of race and Hispanic origin: 2010 census briefs. 2010. http://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf
  • Blessman DJ. Chronic hepatitis C in the Hispanic/Latino population living in the United States: a literature review. Gastroenterology Nurs 2008; 31(1):17–25.
  • Lepe R, Layden‐Almer J, Layden T, Cotler S. Ethnic differences in the presentation of chronic hepatitis C. J Viral Hepatitis 2006; 13(2):116–20.
  • Fisher DG, Reynolds GL, Jaffe A, Perez MJ. Hepatitis and human immunodeficiency virus co-infection among injection drug users in Los Angeles County, California. J Addict Dis 2006; 25(2):25–32.
  • Cheung RC, Currie S, Shen H, et al. Chronic hepatitis C in Latinos: natural history, treatment eligibility, acceptance, and outcomes. Am J Gastroentero 2005; 100(10):2186–93.
  • Trooskin SB, Navarro VJ, Winn RJ, et al. Hepatitis C risk assessment, testing, and referral for treatment in urban primary care: role of race and ethnicity. World J Gastroentero 2007; 13(7):1074.
  • Lelutiu-Weinberger C, Pouget ER, Des Jarlais DD, et al. A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups. Soc Sci Med 2009; 68(3):579–90.
  • Rodríguez-Torres M. Chronic hepatitis C in the Latino population. Curr Hepatitis Reports 2008; 7(3):106–12.
  • Rodríguez-Torres M. Latinos and chronic hepatitis C: a singular population. Clin Gastroentero Hepatology 2008; 6(5):484–90.
  • Fox RK, Currie SL, Evans J, et al. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis 2005; 41(2):177–86.
  • Fisher D, Fenaughty A, Paschane A, Paschane D, Cagle HH, Orr S. Hepatitis C virus infection among Alaskan drug users. Am J Pub Health 1997; 87(10):1722–4.
  • Cagle HH, Jacob J, Homan CE, Williams JL, Christensen CJ, McMahon BJ. Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992. Arch Ped Adolescent Med 2007; 161(2):125–30.
  • Carney K, Dhalla S, Aytaman A, Tenner CT, Francois F. Association of tattooing and hepatitis C virus infection: a multicenter case‐control study. Hepatology 2013; 57(6):2117–23.
  • Tohme RA, Xing J, Liao Y, Holmberg SD. Hepatitis C testing, infection, and linkage to care among racial and ethnic minorities in the United States, 2009–2010. Am J Pub Health Jan 2013; 103(1):112–9.
  • Teutsch S, Luciani F, Scheuer N, et al. Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health 2010; 10(1):633.
  • Burns L, Conroy E, Mattick RP. Main reasons for hospital admissions by women with a history of methadone maintenance. Drug Alcohol Rev 2010; 29(6):669–75.
  • Buxton JA, Kuo ME, Ramji S, Yu A, Krajden M. Methadone use in relation to hepatitis C virus testing in British Columbia. Canadian J Public Health/Revue Canadienne de Sante'e Publique 2010; 101(6):491–4.
  • Harris M, Rhodes T. Methadone diversion as a protective strategy: the harm reduction potential of “generous constraints.” Int J Drug Policy 2013; 24(6):e43–e50.
  • Peles E, Schreiber S, Adelson M. Characteristics and outcome of minority group patients in methadone maintenance treatment. J Psychoactive Drugs 2014; 46(4):317–24.
  • Edwards J, Fisher DG, Johnson ME, Reynolds GL, Redpath D. Test–retest reliability of self-reported drug treatment variables. J Subst Abuse Treat 2007; 33(1):7–11.
  • Fisher DG, Reynolds GL, Wood MM, Johnson ME. Reliability of arrest and incarceration questions on the Risk Behavior Assessment. Crime Delinquency 2004; 50(1):24–31.
  • Dowling-Guyer S, Johnson ME, Fisher DG, et al. Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment 1994; 1(4):383–92.
  • Cagle H, Fisher D, Kastner A, Fenaughty A, Thurmond R. Classification of drug users' skin lesions using photographs: a method for corroborating HIV risk. Paper presented at International Conference on AIDS 1998.
  • Hosmer DW, Lemeshow S. Applied logistic regression. Hoboken, NJ: John Wiley & Sons, Inc., 2005.
  • Agresti A. An introduction to categorical data analysis, 2nd ed., Hoboken, NJ: Wiley, 2007.
  • Perez C, Suarez E, Torres E. Epidemiology of hepatitis C infection and its public health implications in Puerto Rico. Puerto Rico Health Sci J 2004; 23(2 Suppl):11.
  • Gelberg L, Robertson MJ, Arangua L, et al. Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles. Pub Health Rep 2012; 127(4):407–21.
  • Gonzales R, Marinelli-Casey P, Shoptaw S, Ang A, Rawson RA. Hepatitis C virus infection among methamphetamine-dependent individuals in outpatient tre-atment. J Subst Abuse Treat 2006; 31(2):195–202.
  • Klevens RM, Hu DJ, Jiles R, Holmberg SD. Evolving epidemiology of hepatitis C virus in the United States. Clin Infect Dis 2012; 55(Suppl 1):S3–S9.
  • Mahajan R, Liu SJ, Klevens RM, Holmberg SD. Indications for testing among reported cases of Hepatitis C Virus infection from Enhanced Hepatitis Surveillance sites in the United States, 2004–2010. Am J Pub Health 2013; 103(8):1445–9.
  • Nyamathi AM, Dixon EL, Wiley D, Christiani A, Lowe A. Hepatitis C virus infection among homeless men referred from a community clinic. Western J Nurs Res June 1, 2006 2006; 28(4):475–88.
  • Teutsch S, Luciani F, Scheuer N, et al. Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health 2010; 10:633.
  • Buxton JA, Kuo ME, Ramji S, Yu A, Krajden M. Methadone use in relation to hepatitis C virus testing in British Columbia. Canadian J Pub Health 2010; 10(6):491–4.
  • Dolan KA, Wodak AD, Hall WD. Methadone maintenance treatment reduces heroin injection in New South Wales prisons. Drug Alcohol Rev 1998; 17(2):153–8.
  • Fisher DG, Reynolds GL, Moreno-Branson CM, et al. Drug treatment needs of Hispanic drug users in Long Beach, California. J Drug Issues 2004; 34(4):879–94.
  • Stein JA, Nyamathi A. Correlates of hepatitis C virus infection in homeless men: a latent variable approach. Drug Alcohol Depend 2004; 75(1):89–95.
  • CDC. CDC Health Disparities and Inequalities Report—United States, 2013. MMWR 62(3), 2013.
  • Klein R, Huang D. Defining and measuring disparities, inequities, and inequalities in the Healthy People Initiative National Center for Health Statistics. Centers for Disease Control and Prevention and Healthy People 2010. 2010. http://www.cdc.gov/nchs/ppt/nchs2010/41_Klein.pdf
  • Reynolds GL, Fisher DG, Jaffe A, Edwards J. Follow-up for medical care among drug users with hepatitis C. Eval Health Prof 2006; 29(4):355–66.
  • Estrada AL. Health disparities among African-American and Hispanic drug injectors-HIV, AIDS, hepatitis B virus and hepatitis C virus: a review. AIDS. 2005; 19:S47–S52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.